nach oben

Neurological Sciences

Erschienen in:

24.03.2022 | COVID-19 | COVID-19 Zur Zeit gratis

The association between stroke and COVID-19-related mortality: a systematic review and meta-analysis based on adjusted effect estimates

verfasst von: Shuwen Li, Jiahao Ren, Hongjie Hou, Xueya Han, Jie Xu, Guangcai Duan, Yadong Wang, Haiyan Yang

Erschienen in: Neurological Sciences | Ausgabe 7/2022

Einloggen, um Zugang zu erhalten

Abstract

Objective

To investigate the association between stroke and the risk for mortality among coronavirus disease 2019 (COVID-19) patients.

Methods

We performed systematic searches through electronic databases including PubMed, Embase, Scopus, and Web of Science to identify potential articles reporting adjusted effect estimates on the association of stroke with COVID-19-related mortality. To estimate pooled effects, the random-effects model was applied. Subgroup analyses and meta-regression were performed to explore the possible sources of heterogeneity. The stability of the results was assessed by sensitivity analysis. Publication bias was evaluated by Begg’s test and Egger’s test.

Results

This meta-analysis included 47 studies involving 7,267,055 patients. The stroke was associated with higher COVID-19 mortality (pooled effect = 1.30, 95% confidence interval (CI): 1.16–1.44; I² = 89%, P < 0.01; random-effects model). Subgroup analyses yielded consistent results among area, age, proportion of males, setting, cases, effect type, and proportion of severe COVID-19 cases. Statistical heterogeneity might result from the different effect type according to the meta-regression (P = 0.0105). Sensitivity analysis suggested that our results were stable and robust. Both Begg’s test and Egger’s test indicated that potential publication bias did not exist.

Conclusion

Stroke was independently associated with a significantly increased risk for mortality in COVID-19 patients.

Gao Y, Chen Y, Liu M, Niu M, Song Z, Yan M, Tian J (2021) Nervous system diseases are associated with the severity and mortality of patients with COVID-19: a systematic review and meta-analysis. Epidemiol Infect 149:e66PubMedCrossRef

Aggarwal G, Lippi G, Michael Henry B (2020) Cerebrovascular disease is associated with an increased disease severity in patients with coronavirus disease 2019 (COVID-19): a pooled analysis of published literature. Int J Stroke 15(4):385–389PubMedCrossRef

Liang X, Shi L, Wang Y, Xiao W, Duan G, Yang H, Wang Y (2020) The association of hypertension with the severity and mortality of COVID-19 patients: evidence based on adjusted effect estimates. J Infect 81(3):e44–e47PubMedPubMedCentralCrossRef

Mesas AE, Cavero-Redondo I, Alvarez-Bueno C, Sarria Cabrera MA, Maffei de Andrade S, Sequi-Dominguez I, Martinez-Vizcaino V (2020) Predictors of in-hospital COVID-19 mortality: a comprehensive systematic review and meta-analysis exploring differences by age, sex and health conditions. PLoS One 15(11):e0241742PubMedPubMedCentralCrossRef

Nasiri MJ, Haddadi S, Tahvildari A, Farsi Y, Arbabi M, Hasanzadeh S, Jamshidi P, Murthi M, Mirsaeidi M (2020) COVID-19 Clinical characteristics, and sex-specific risk of mortality: systematic review and meta-analysis. Front Med (Lausanne) 7:459CrossRef

Xu J, Xiao W, Liang X, Zhang P, Shi L, Wang Y, Wang Y, Yang H (2020) The association of cerebrovascular disease with adverse outcomes in COVID-19 patients: a meta-analysis based on adjusted effect estimates. J Stroke Cerebrovasc Dis 29(11):105283PubMedPubMedCentralCrossRef

Yang H, Liang X, Hou H, Xu J, Shi L, Wang Y (2021) The association of dementia with COVID-19 mortality: Evidence based on adjusted effect estimates. J Infect 82(5):e6–e10PubMedPubMedCentralCrossRef

Yang H, Xu J, Liang X, Shi L, Wang Y (2021) Autoimmune diseases are independently associated with COVID-19 severity: evidence based on adjusted effect estimates. J Infect 82(4):e23–e26PubMedCrossRef

Muhammad R, Ogunti R, Ahmed B, Munawar M, Donaldson S, Sumon M, Kibreab A, Thomas AN, Mehari A (2022) Clinical characteristics and predictors of mortality in minority patients hospitalized with COVID-19 infection. J Racial Ethn Health Disparities 9(1):335–345PubMedCrossRef

10.

Lee JH, Hwang YM, Cho Y, Oh IY (2021) Prognostic impact of atrial fibrillation in patients with severe acute respiratory syndrome coronavirus 2 infection. Medicine (Baltimore) 100(33):e26993CrossRef

11.

B. Ahlstrom, R. Frithiof, M. Hultstrom, I.M. Larsson, G. Strandberg, M. Lipcsey (2021) The swedish covid-19 intensive care cohort: Risk factors of ICU admission and ICU mortality, Acta Anaesthesiol Scand

12.

Alguwaihes AM, Al-Sofiani ME, Megdad M, Albader SS, Alsari MH, Alelayan A, Alzahrani SH, Sabico S, Al-Daghri NM, Jammah AA (2020) Diabetes and Covid-19 among hospitalized patients in Saudi Arabia: a single-centre retrospective study. Cardiovasc Diabetol 19(1):205PubMedPubMedCentralCrossRef

13.

Alwafi H, Naser AY, Qanash S, Brinji AS, Ghazawi MA, Alotaibi B, Alghamdi A, Alrhmani A, Fatehaldin R, Alelyani A, Basfar A, AlBarakati A, Alsharif GF, Obaid EF, Shabrawishi M (2021) Predictors of length of hospital stay, mortality, and outcomes among hospitalised COVID-19 patients in Saudi Arabia: a cross-sectional study. J Multidiscip Healthc 14:839–852PubMedPubMedCentralCrossRef

14.

Aoun M, Khalil R, Mahfoud W, Fatfat H, Bou Khalil L, Alameddine R, Afiouni N, Ibrahim I, Hassan M, Zarzour H, Jebai A, Khalil NM, Tawil L, Mechref Z, El Imad Z, Chamma F, Khalil A, Zeidan S, El Ghoul B, Dahdah G, Mouawad S, Azar H, Chahine KA, Kallab S, Moawad B, Fawaz A, Homsi J, Tabaja C, Delbani M, Kallab R, Hoballah H, Haykal W, Fares N, Rahal W, Mroueh W, Youssef M, Rizkallah J, Sebaaly Z, Dfouni A, Ghosn N, Nawfal N, Jaoude WA, Bassil N, Maroun T, Bassil N, Beaini C, Haddad B, Moubarak E, Rabah H, Attieh A, Finianos S, Chelala D (2021) Age and multimorbidities as poor prognostic factors for COVID-19 in hemodialysis: a Lebanese national study. BMC Nephrol 22(1):73PubMedPubMedCentralCrossRef

15.

Atkins JL, Masoli JAH, Delgado J, Pilling LC, Kuo CL, Kuchel GA, Melzer D (2020) Preexisting comorbidities predicting COVID-19 and mortality in the UK biobank community cohort. J Gerontol A Biol Sci Med Sci 75(11):2224–2230PubMedPubMedCentralCrossRef

16.

Azarkar Z, Salehiniya H, Kazemi T, Abbaszadeh H (2021) Epidemiological, imaging, laboratory, and clinical characteristics and factors related to mortality in patients with COVID-19: a single-center study. Osong Public Health Res Perspect 12(3):169–176PubMedPubMedCentralCrossRef

17.

Bonnet G, Weizman O, Trimaille A, Pommier T, Cellier J, Geneste L, Panagides V, Marsou W, Deney A, Attou S, Delmotte T, Ribeyrolles S, Chemaly P, Karsenty C, Giordano G, Gautier A, Chaumont C, Guilleminot P, Sagnard A, Pastiero J, Ezzouhairi N, Perin B, Zakine C, Levasseur T, Ma I, Chavignier D, Noirclerc N, Darmon A, Mevelec M, Duceau B, Sutter W, Mika D, Fauvel C, Pezel T, Waldmann V, Cohen A, Critical C-FI (2021) Characteristics and outcomes of patients hospitalized for COVID-19 in France: the Critical COVID-19 France (CCF) study. Arch Cardiovasc Dis 114(5):352–363PubMedPubMedCentralCrossRef

18.

D. Bushman, A. Davidson, P. Pathela, S.K. Greene, D. Weiss, V. Reddy, N. Team, J. Latash (2021) Risk Factors for death among hospitalized patients aged 21–64 years diagnosed with COVID-19-New York city, March 13-April 9, 2020, J Racial Ethn Health Disparities

19.

Caro-Codon J, Rey JR, Buno A, Iniesta AM, Rosillo SO, Castrejon-Castrejon S, Merino C, Marco I, Martinez LA, Garcia-Veas JM, Martin-Polo L, Rodriguez-Sotelo L, Martinez-Cossiani M, Gonzalez-Valle L, Herrero A, Lopez-de-Sa E, Merino JL, Investigators C-C (2021) Characterization of myocardial injury in a cohort of patients with SARS-CoV-2 infection. Med Clin (Barc) 157(6):274–280CrossRef

20.

Chai C, Feng X, Lu M, Li S, Chen K, Wang H, Wang W, Tang Z, Cheng G, Wu X, Li Y, Wen Y, Da B, Fan H, Wang L, Ai F, Li W, Peng C, Zhang H, Wen S, Zhang J, Weng Y, Tang Z (2021) One-year mortality and consequences of COVID-19 in cancer patients: a cohort study. IUBMB Life 73(10):1244–1256PubMedCrossRef

21.

Clift AK, Coupland CAC, Keogh RH, Diaz-Ordaz K, Williamson E, Harrison EM, Hayward A, Hemingway H, Horby P, Mehta N, Benger J, Khunti K, Spiegelhalter D, Sheikh A, Valabhji J, Lyons RA, Robson J, Semple MG, Kee F, Johnson P, Jebb S, Williams T, Hippisley-Cox J (2020) Living risk prediction algorithm (QCOVID) for risk of hospital admission and mortality from coronavirus 19 in adults: national derivation and validation cohort study. BMJ 371:m3731PubMedCrossRef

22.

F.R.S.S.S.C.I (2020) consortium, contributors, Severity of COVID-19 and survival in patients with rheumatic and inflammatory diseases: data from the French RMD COVID-19 cohort of 694 patients, Ann Rheum Dis

23.

Cummins L, Ebyarimpa I, Cheetham N, Tzortziou Brown V, Brennan K, Panovska-Griffiths J (2021) Factors associated with COVID-19 related hospitalisation, critical care admission and mortality using linked primary and secondary care data. Influenza Other Respir Viruses 15(5):577–588PubMedPubMedCentralCrossRef

24.

Efros O, Barda N, Meisel E, Leibowitz A, Fardman A, Rahav G, Klempfner R, Grossman E (2021) Myocardial injury in hospitalized patients with COVID-19 infection-risk factors and outcomes. PLoS One 16(2):e0247800PubMedPubMedCentralCrossRef

25.

Eskandar EN, Altschul DJ, de la Garza Ramos R, Cezayirli P, Unda SR, Benton J, Dardick J, Toma A, Patel N, Malaviya A, Flomenbaum D, Fernandez-Torres J, Lu J, Holland R, Burchi E, Zampolin R, Hsu K, McClelland A, Burns J, Erdfarb A, Malhotra R, Gong M, Semczuk P, Gursky J, Ferastraoaru V, Rosengard J, Antoniello D, Labovitz D, Esenwa C, Milstein M, Boro A, Mehler MF (2021) Neurologic syndromes predict higher in-hospital mortality in COVID-19. Neurology 96(11):e1527–e1538PubMedPubMedCentralCrossRef

26.

Galvez-Barron C, Arroyo-Huidobro M, Minarro A, Ananos G, Chamero A, Martin M, Gris C, Avalos JL, Capielo AM, Ventosa E, Tremosa G, Rodriguez-Molinero A, C.-r.g.o. CSAPG (2022) COVID-19: clinical presentation and prognostic factors of severe disease and mortality in the oldest-old population: a cohort study. Gerontology 68(1):30–43PubMedCrossRef

27.

D. Graziani, J.B. Soriano, C. Del Rio-Bermudez, D. Morena, T. Diaz, M. Castillo, M. Alonso, J. Ancochea, S. Lumbreras, J.L. Izquierdo (2020) Characteristics and prognosis of COVID-19 in patients with COPD, J Clin Med 9(10)

28.

Hobbs ALV, Turner N, Omer I, Walker MK, Beaulieu RM, Sheikh M, Spires SS, Fiske CT, Dare R, Goorha S, Thapa P, Gnann J, Wright J, Nelson GE (2021) Risk factors for mortality and progression to severe COVID-19 disease in the Southeast region in the United States: a report from the SEUS Study Group. Infect Control Hosp Epidemiol 42(12):1464–1472PubMedCrossRef

29.

F. Isik, M. Cap, A. Akyuz, O. Bilge, B. Aslan, U. Inci, I. Kaya, E. Tastan, M. Oksul, N.K. Cap, A. Karagoz, E. Baysal (2021) The effect of resistant hypertension on in-hospital mortality in patients hospitalized with COVID-19, J Hum Hypertens

30.

Kelly JD, Bravata DM, Bent S, Wray CM, Leonard SJ, Boscardin WJ, Myers LJ, Keyhani S (2021) Association of social and behavioral risk factors with mortality among US veterans with COVID-19. JAMA Netw Open 4(6):e2113031PubMedPubMedCentralCrossRef

31.

Kummer BR, Klang E, Stein LK, Dhamoon MS, Jette N (2020) History of stroke is independently associated with in-hospital death in patients with COVID-19. Stroke 51(10):3112–3114PubMedCrossRef

32.

S.F. Ling, E. Broad, R. Murphy, J.M. Pappachan, S. Pardesi-Newton, M.F. Kong, E.B. Jude (2020) High-dose cholecalciferol booster therapy is associated with a reduced risk of mortality in patients with COVID-19: a cross-sectional multi-centre observational study, Nutrients 12(12)

33.

Liu J, Zhang S, Dong X, Li Z, Xu Q, Feng H, Cai J, Huang S, Guo J, Zhang L, Chen Y, Zhu W, Du H, Liu Y, Wang T, Chen L, Wen Z, Annane D, Qu J, Chen D (2020) Corticosteroid treatment in severe COVID-19 patients with acute respiratory distress syndrome. J Clin Invest 130(12):6417–6428PubMedPubMedCentralCrossRef

34.

Marques M, Correig E, Ibarretxe D, Anoro E, Antonio Arroyo J, Jerico C, Borrallo RM, Miret M, Naf S, Pardo A, Perea V, Perez-Bernalte R, Ramirez-Montesinos R, Royuela M, Soler C, Urquizu-Padilla M, Zamora A, Pedro-Botet J, S.-X.r. group, Masana L, Domingo JL (2022) Long-term exposure to PM10 above WHO guidelines exacerbates COVID-19 severity and mortality. Environ Int 158:106930PubMedCrossRef

35.

Miller J, Fadel RA, Tang A, Perrotta G, Herc E, Soman S, Nair S, Hanna Z, Zervos MJ, Alangaden G, Brar I, Suleyman G (2021) The impact of sociodemographic factors, comorbidities, and physiologic responses on 30-day mortality in coronavirus disease 2019 (COVID-19) patients in metropolitan detroit. Clin Infect Dis 72(11):e704–e710PubMedCrossRef

36.

Nimkar A, Naaraayan A, Hasan A, Pant S, Durdevic M, Suarez CN, Elenius H, Hambardzumyan A, Lakshmi K, Mandel M, Jesmajian S (2020) Incidence and risk factors for acute kidney injury and its effect on mortality in patients hospitalized from COVID-19. Mayo Clin Proc Innov Qual Outcomes 4(6):687–695PubMedPubMedCentralCrossRef

37.

E. Ouattara, A. Bruandet, A. Borde, X. Lenne, F. Binder-Foucard, M. Le-Bourhis-Zaimi, J. Muller, P. Tran Ba Loc, F. Seguret, S. Tezenas du Montcel, V. Gilleron (2020) Risk factors of mortality among patients hospitalised with COVID-19 in a critical care or hospital care unit: analysis of the French national medicoadministrative database, BMJ Open Respir Res 8(1)

38.

Panagides V, Vincent F, Weizman O, Jonveaux M, Trimaille A, Pommier T, Cellier J, Geneste L, Marsou W, Deney A, Attou S, Delmotte T, Fauvel C, Ezzouhairi N, Perin B, Zakine C, Levasseur T, Ma I, Chavignier D, Noirclerc N, Darmon A, Mevelec M, Karsenty C, Duceau B, Sutter W, Mika D, Pezel T, Waldmann V, Ternacle J, Cohen A, Bonnet G, Critical C-FI (2021) History of heart failure in patients with coronavirus disease 2019: Insights from a French registry. Arch Cardiovasc Dis 114(5):415–425PubMedPubMedCentralCrossRef

39.

Perez-Guzman PN, Daunt A, Mukherjee S, Crook P, Forlano R, Kont MD, Lochen A, Vollmer M, Middleton P, Judge R, Harlow C, Soubieres A, Cooke G, White PJ, Hallett TB, Aylin P, Ferguson N, Hauck K, Thursz MR, Nayagam S (2021) Clinical characteristics and predictors of outcomes of hospitalized patients with coronavirus disease 2019 in a multiethnic London national health service trust: a retrospective cohort study. Clin Infect Dis 73(11):e4047–e4057PubMedCrossRef

40.

Puebla Neira DA, Watts A, Seashore J, Duarte A, Nishi SP, Polychronopoulou E, Kuo YF, Baillargeon J, Sharma G (2021) Outcomes of patients with COPD hospitalized for coronavirus disease 2019. Chronic Obstr Pulm Dis 8(4):517–527PubMedPubMedCentral

41.

Reilev M, Kristensen KB, Pottegard A, Lund LC, Hallas J, Ernst MT, Christiansen CF, Sorensen HT, Johansen NB, Brun NC, Voldstedlund M, Stovring H, Thomsen MK, Christensen S, Gubbels S, Krause TG, Molbak K, Thomsen RW (2020) Characteristics and predictors of hospitalization and death in the first 11 122 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: a nationwide cohort. Int J Epidemiol 49(5):1468–1481PubMedPubMedCentralCrossRef

42.

Rossi L, Malagoli A, Biagi A, Zanni A, Sticozzi C, Comastri G, Pannone L, Gandolfi S, Vergara P, Villani GQ (2021) Renin-angiotensin system inhibitors and mortality in patients with COVID-19. Infection 49(2):287–294PubMedCrossRef

43.

Semenzato L, Botton J, Drouin J, Cuenot F, Dray-Spira R, Weill A, Zureik M (2021) Chronic diseases, health conditions and risk of COVID-19-related hospitalization and in-hospital mortality during the first wave of the epidemic in France: a cohort study of 66 million people. Lancet Reg Health Eur 8:100158PubMedPubMedCentralCrossRef

44.

Sheshah E, Sabico S, Albakr RM, Sultan AA, Alghamdi KS, Al Madani K, Alotair HA, Al-Daghri NM (2021) Prevalence of diabetes, management and outcomes among Covid-19 adult patients admitted in a specialized tertiary hospital in Riyadh. Saudi Arabia, Diabetes Res Clin Pract 172:108538PubMedCrossRef

45.

Vogels Y, Pouwels S, van Oers J, Ramnarain D (2021) Characteristics and risk factors associated with mortality in critically ill patients with COVID-19. Cureus 13(4):e14442PubMedPubMedCentral

46.

B. Wang, B.S. Glicksberg, G.N. Nadkarni, D. Vashishth (2021) Evaluation and management of COVID-19-related severity in people with type 2 diabetes, BMJ Open Diabetes Res Care 9(1)

47.

Zagidullin NS, Motloch LJ, Musin TI, Bagmanova ZA, Lakman IA, Tyurin AV, Gumerov RM, Enikeev D, Cai B, Gareeva DF, Davtyan PA, Gareev DA, Talipova HM, Badykov MR, Jirak P, Kopp K, Hoppe UC, Pistulli R, Pavlov VN (2021) J-waves in acute COVID-19: a novel disease characteristic and predictor of mortality? PLoS One 16(10):e0257982PubMedPubMedCentralCrossRef

48.

Zerbo O, Lewis N, Fireman B, Goddard K, Skarbinski J, Sejvar JJ, Azziz-Baumgartner E, Klein NP (2022) Population-based assessment of risks for severe COVID-19 disease outcomes. Influenza Other Respir Viruses 16(1):159–165PubMedCrossRef

49.

Lugon JR, Neves P, Pio-Abreu A, do Nascimento MM, Sesso R, C.-H.-B. Investigators (2022) Evaluation of central venous catheter and other risk factors for mortality in chronic hemodialysis patients with COVID-19 in Brazil. Int Urol Nephrol 54(1):193–199PubMedCrossRef

50.

Bandera A, Nobili A, Tettamanti M, Harari S, Bosari S, Mannucci PM, C.-N.W. Group (2022) Clinical factors associated with death in 3044 COVID-19 patients managed in internal medicine wards in Italy: comment. Intern Emerg Med 17(1):299–302PubMedCrossRef

51.

Lu Y, Jiao Y, Graham DJ, Wu Y, Wang J, Menis M, Chillarige Y, Wernecke M, Kelman J, Forshee RA, Izurieta HS (2022) Risk factors for COVID-19 deaths among elderly nursing home medicare beneficiaries in the prevaccine period. J Infect Dis 225(4):567–577PubMedCrossRef

52.

R. Kvale, K.H. Bonaa, R. Forster, K. Gravningen, P.B. Juliusson, T.A. Myklebust Does a history of cardiovascular disease or cancer affect mortality after SARS-CoV-2 infection?, Tidsskr Nor Laegeforen 140(2) (2021).

53.

Gonzalez-Fajardo JA, Ansuategui M, Romero C, Comanges A, Gomez-Arbelaez D, Ibarra G, Garcia-Gutierrez A (2021) Mortality of COVID-19 patients with vascular thrombotic complications. Med Clin (Engl Ed) 156(3):112–117

54.

Fan FSY, Yip TCF, Yiu B, Lam B, Au L, Lau AY, Ip B, Soo Y, Leung TW, Li T, Lui G, Wong GLH, Mok V (2021) Neurological diseases and risk of mortality in patients with COVID-19 and SARS: a territory-wide study in Hong Kong. J Neurol Neurosurg Psychiatry 92(12):1356–1358PubMedCrossRef

55.

Gupta A, Madhavan MV, Poterucha TJ, DeFilippis EM, Hennessey JA, Redfors B, Eckhardt C, Bikdeli B, Platt J, Nalbandian A, Elias P, Cummings MJ, Nouri SN, Lawlor M, Ranard LS, Li J, Boyle C, Givens R, Brodie D, Krumholz HM, Stone GW, Sethi SS, Burkhoff D, Uriel N, Schwartz A, Leon MB, Kirtane AJ, Wan EY, Parikh SA (2021) Association between antecedent statin use and decreased mortality in hospitalized patients with COVID-19. Nat Commun 12(1):1325PubMedPubMedCentralCrossRef

56.

Gorelick PB (2019) The global burden of stroke: persistent and disabling. Lancet Neurol 18(5):417–418PubMedCrossRef

57.

Ho CH, Lin WC, Hsu YF, Lee IH, Hung YC (2018) One-year risk of pneumonia and mortality in patients with poststroke dysphagia: a nationwide population-based study. J Stroke Cerebrovasc Dis 27(5):1311–1317PubMedCrossRef

58.

Singh RJ, Chen S, Ganesh A, Hill MD (2018) Long-term neurological, vascular, and mortality outcomes after stroke. Int J Stroke 13(8):787–796PubMedCrossRef

59.

Smeeth L, Thomas SL, Hall AJ, Hubbard R, Farrington P, Vallance P (2004) Risk of myocardial infarction and stroke after acute infection or vaccination. N Engl J Med 351(25):2611–2618PubMedCrossRef

60.

Boehme AK, Luna J, Kulick ER, Kamel H, Elkind MSV (2018) Influenza-like illness as a trigger for ischemic stroke. Ann Clin Transl Neurol 5(4):456–463PubMedPubMedCentralCrossRef

61.

Pranata R, Huang I, Lim MA, Wahjoepramono EJ (2020) Impact of cerebrovascular and cardiovascular diseases on mortality and severity of COVID-19-systematic review, meta-analysis, and meta-regression. J Stroke Cerebrovasc Dis 29(8):104949PubMedPubMedCentralCrossRef

62.

Bibas M, Biava G, Antinori A (2011) HIV-Associated venous thromboembolism. Mediterr J Hematol Infect Dis 3(1):e2011030PubMedPubMedCentralCrossRef

63.

Gupta N, Zhao YY, Evans CE (2019) The stimulation of thrombosis by hypoxia. Thromb Res 181:77–83PubMedCrossRef

64.

Song P, Li W, Xie J, Hou Y, You C (2020) Cytokine storm induced by SARS-CoV-2. Clin Chim Acta 509:280–287PubMedPubMedCentralCrossRef

65.

P.A. Lapchak, Q. Wu (2011) Vascular dysfunction in brain hemorrhage: translational pathways to developing new treatments from old targets, J Neurol Neurophysiol 2011

66.

Tan YK, Goh C, Leow AST, Tambyah PA, Ang A, Yap ES, Tu TM, Sharma VK, Yeo LLL, Chan BPL, Tan BYQ (2020) COVID-19 and ischemic stroke: a systematic review and meta-summary of the literature. J Thromb Thrombolysis 50(3):587–595PubMedCrossRef

67.

Yaghi S, Ishida K, Torres J, Mac Grory B, Raz E, Humbert K, Henninger N, Trivedi T, Lillemoe K, Alam S, Sanger M, Kim S, Scher E, Dehkharghani S, Wachs M, Tanweer O, Volpicelli F, Bosworth B, Lord A, Frontera J (2020) SARS-CoV-2 and stroke in a New York healthcare system. Stroke 51(7):2002–2011PubMedCrossRef

68.

Ladopoulos T, Zand R, Shahjouei S, Chang JJ, Motte J, Charles James J, Katsanos AH, Kerro A, Farahmand G, Vaghefi Far A, Rahimian N, Ebrahimzadeh SA, Abedi V, Papathanasiou M, Labedi A, Schneider R, Lukas C, Tsiodras S, Tsivgoulis G, Krogias C (2021) COVID-19: neuroimaging features of a pandemic. J Neuroimaging 31(2):228–243PubMedPubMedCentralCrossRef

69.

Nannoni S, de Groot R, Bell S, Markus HS (2021) Stroke in COVID-19: a systematic review and meta-analysis. Int J Stroke 16(2):137–149PubMedCrossRef

70.

M.S. Dhamoon, A. Thaler, K. Gururangan, A. Kohli, D. Sisniega, D. Wheelwright, C. Mensching, J.T. Fifi, M.G. Fara, N. Jette, E. Cohen, P. Dave, A.C. DiRisio, J. Goldstein, E.M. Loebel, N.A. Mayman, A. Sharma, D.S. Thomas, R.D. Vega Perez, M.R. Weingarten, H.H. Wen, S. Tuhrim, L.K. Stein, I. Mount Sinai Stroke, Acute cerebrovascular events with COVID-19 infection, Stroke 52(1) (2021) 48–56.

71.

Siepmann T, Sedghi A, Simon E, Winzer S, Barlinn J, de With K, Mirow L, Wolz M, Gruenewald T, Schroettner P, von Bonin S, Pallesen LP, Rosengarten B, Schubert J, Lohmann T, Machetanz J, Spieth P, Koch T, Bornstein S, Reichmann H, Puetz V, Barlinn K (2021) Increased risk of acute stroke among patients with severe COVID-19: a multicenter study and meta-analysis. Eur J Neurol 28(1):238–247PubMedCrossRef

Titel: The association between stroke and COVID-19-related mortality: a systematic review and meta-analysis based on adjusted effect estimates
verfasst von: Shuwen Li
Jiahao Ren
Hongjie Hou
Xueya Han
Jie Xu
Guangcai Duan
Yadong Wang
Haiyan Yang
Publikationsdatum: 24.03.2022
Verlag: Springer International Publishing
Schlagwort: COVID-19
Erschienen in: Neurological Sciences / Ausgabe 7/2022
Print ISSN: 1590-1874
Elektronische ISSN: 1590-3478
DOI: https://doi.org/10.1007/s10072-022-06024-9

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Objective

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 7/2022

A splice altering variant in NDRG1 gene causes Charcot-Marie-Tooth disease, type 4D

Increase in CGRP levels in a case of hemicrania continua normalizes after a successful response to galcanezumab

Health care providers’ effect on long-term mortality after the first-ever stroke: application of shared frailty survival models

Diagnostic approach, therapeutic strategies, and surgical indications in intradural thoracic disc herniation associated with CSF leak, intracranial hypotension, and CNS superficial siderosis

Neurophysiological challenges in myasthenia gravis associated with MuSK antibodies: a case report

A new Chinese family with HTRA1 mutation associated with CARASIL